Jove
Visualize
Contact Us

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Mitochondria01:37

Mitochondria

13.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.9K
Mitochondrial Membranes01:45

Mitochondrial Membranes

11.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.6K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

7.7K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.7K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
2.6K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

4.4K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Physical Activity on Stroke Risk in Middle-Aged and Older Adults.

Brain and behavior·2026
Same author

Discovery of a mitochondria-targeted propranolol conjugate PL37 that induces mitophagy for potent anti-hemangioma activity.

Bioorganic & medicinal chemistry·2026
Same author

Design, synthesis, and biological evaluation of a multi-layer-linked idebenone derivative targeting mitochondrial dysfunction and neuroinflammation for ischemic stroke.

Bioorganic chemistry·2026
Same author

Discovery of Imidazo[2,1-<i>b</i>][1,3,4]thiadiazole-Based MNK Inhibitors with Anti-inflammatory Efficacy via Dual Suppression of eIF4E Phosphorylation and NF-κB Signaling.

Journal of medicinal chemistry·2026
Same author

Design, Synthesis, and Structure-Activity Relationship Study of μ-Conotoxin KIIIA toward Na<sub>V</sub>1.4.

Journal of medicinal chemistry·2026
Same author

A mitochondria-targeted idebenone derivative W1a mitigates cerebral ischemia-reperfusion injury by preserving mitochondrial integrity and suppressing neuroinflammation.

Bioorganic chemistry·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 23, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
08:39

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

8.1K

Recent advances in small molecules for improving mitochondrial disorders.

Liying Meng1, Guanzhao Wu1

  • 1Department of Central Laboratory and Mitochondrial Medicine Laboratory, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University Qingdao China guanzhao.wu@email.sdu.edu.cn.

RSC Advances
|July 12, 2023
PubMed
Summary

Small-molecule therapies offer promising treatments for mitochondrial disorders, a group of diseases with limited therapeutic options. Further research into novel bioactive compounds is crucial for improving mitochondrial function and patient outcomes.

More Related Videos

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.6K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

4.0K

Related Experiment Videos

Last Updated: Jul 23, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
08:39

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

8.1K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.6K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

4.0K

Area of Science:

  • Biochemistry
  • Genetics
  • Pharmacology

Background:

  • Mitochondrial disorders are implicated in diverse human diseases, ranging from rare genetic conditions to complex acquired pathologies.
  • Understanding the molecular mechanisms underlying these disorders has advanced significantly due to progress in molecular biology.
  • Current therapeutic strategies for mitochondrial disorders remain limited, necessitating the exploration of novel treatment approaches.

Purpose of the Study:

  • To review recent advancements in the development of small-molecule therapies for mitochondrial disorders.
  • To provide a comprehensive overview of studies evaluating the efficacy of bioactive compounds in modulating mitochondrial function.
  • To highlight the urgent need for novel small molecules that can effectively ameliorate mitochondrial dysfunction.

Main Methods:

  • Literature review of recent scientific publications on mitochondrial disorders and small-molecule interventions.
  • Analysis of fundamental studies investigating the effects of bioactive compounds on mitochondrial function.
  • Synthesis of information on the design and evaluation of novel small molecules for therapeutic applications.

Main Results:

  • Small-molecule therapies represent a promising avenue for enhancing mitochondrial performance and addressing mitochondrial impairments.
  • Numerous bioactive compounds are under investigation for their potential to treat mitochondrial diseases.
  • The development of specifically designed small molecules is critical for advancing therapeutic options.

Conclusions:

  • Small molecules hold significant therapeutic potential for a range of mitochondrial disorders.
  • Continued research and development of novel small-molecule agents are essential for effective treatment strategies.
  • Targeting mitochondrial function with innovative compounds offers a promising future for managing these debilitating conditions.